Edgewise Therapeutics
EWTX
EWTX
140 hedge funds and large institutions have $1.83B invested in Edgewise Therapeutics in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
+11
Holders Change %
+8.53%
% of All Funds
2.04%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
33
Increased
58
Reduced
30
Closed
21
Calls
$1.06M
Puts
$140K
Net Calls
+$920K
Net Calls Change
+$782K
Top Buyers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$114M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$25.7M |
| 3 |
BlackRock
New York
|
$108M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
$46.9M |
| 5 |
Millennium Management
New York
|
$20.6M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
$26.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$86.1M |
| 3 |
PA
Perceptive Advisors
New York
|
$33.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$42.3M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
$1.41M |
